18F-FDG PET or PET-CT to evaluate prognosis for head and neck cancer: a meta-analysis (Q46665763)

24 December 2017

meta-analysis

0 references

title

18F-FDG PET or PET-CT to evaluate prognosis for head and neck cancer: a meta-analysis (English)

1 reference

24 December 2017

0 references

1 reference

1 reference

head and neck carcinoma

1 reference

Peng Xie

1

1 reference

24 December 2017

Minghuan Li

2

1 reference

24 December 2017

Hanxi Zhao

3

1 reference

24 December 2017

Xindong Sun

4

1 reference

24 December 2017

Zheng Fu

5

1 reference

24 December 2017

Jinming Yu

6

1 reference

24 December 2017

publication date

13 January 2011

1 reference

24 December 2017

Journal of Cancer Research and Clinical Oncology

published in

1 reference

24 December 2017

volume

137

1 reference

24 December 2017

issue

7

1 reference

24 December 2017

page(s)

1085-1093

1 reference

24 December 2017

https://scigraph.springernature.com/pub.10.1007/s00432-010-0972-y

exact match

0 references

cites work

Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Clinical significance of 18F-FDG uptake by primary sites in patients with diffuse large B cell lymphoma in the head and neck: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Prediction for distant failure in patients with stage M0 nasopharyngeal carcinoma: the role of standardized uptake value

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Metabolic tumor volume of [18F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Prognostic value of FDG uptake by the bone marrow in squamous cell carcinoma of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

The expanding role of systemic therapy in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

FDG-PET. A possible prognostic factor in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Evaluation of the therapeutic effects and recurrence for head and neck cancer after chemoradiotherapy by FDG-PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with technetium-99m methoxyisobutylisonitrile single photon emission computed tomography and computed tomography: comparison with 18-fluoro-2-deoxyglucose positron emi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Utility of FDG PET in patients with squamous cell carcinomas of the oral cavity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Expression of VEGF as prognosticator in primary nasopharyngeal cancer and its relation to EBV status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Radiation response non-invasively imaged by [18F]FDG-PET predicts local tumor control and survival in advanced oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Clinical and prognostic value of [(18)F]FDG-PET for surveillance of oral squamous cell carcinoma after surgical salvage therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Expressions of Ku70 and DNA-PKcs as prognostic indicators of local control in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Metabolic tumor burden predicts for disease progression and death in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Prediction of prognosis using standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose positron emission tomography for nasopharyngeal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Pretreatment primary tumor SUVmax measured by FDG-PET and pathologic tumor depth predict for poor outcomes in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Analysis of prognostic factors of nasopharyngeal carcinoma: impact of in situ hybridization for Epstein-Barr virus encoded small RNA 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Positron emission tomography: an independent indicator of radiocurability in head and neck carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Potential novel application of dual time point SUV measurements as a predictor of survival in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

[18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Glucose transporter 1 gene expression is related to thyroid neoplasms with an unfavorable prognosis: an immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

FDG-PET prediction of head and neck squamous cell cancer outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Tumor response and survival predicted by post-therapy FDG-PET/CT in anal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Measurement of tumor volume by PET to evaluate prognosis in patients with head and neck cancer treated by chemo-radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Ensuring the right PET scan for the right patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Prognostic value of tumor 18F-FDG uptake in patients with untreated extranodal natural killer/T-cell lymphomas of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Combined uptake of [18F]FDG and [18F]FMISO correlates with radiation therapy outcome in head-and-neck cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Prognostic value of 18F-FDG PET in patients with head and neck squamous cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Prognostic value of 18F-FDG PET/CT before and after radiotherapy for locally advanced nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Clinical significance of postradiotherapy [18F]-fluorodeoxyglucose positron emission tomography imaging in management of head-and-neck cancer-a long-term outcome report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0972-Y

Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation

21 January 2018

1 reference

12 December 2020

Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer.

1 reference

12 December 2020

FDG-PET for predicting the prognosis of malignant lymphoma

1 reference

12 December 2020

18F-FDG-PET for evaluation of the response to concurrent chemoradiation therapy with intensity-modulated radiation technique for Stage T4 nasopharyngeal carcinoma

1 reference

12 December 2020

Whole-body 18F-FDG PET in recurrent or metastatic nasopharyngeal carcinoma

1 reference

12 December 2020

Comparison of changes in tumor metabolic activity and tumor size during chemotherapy of adenocarcinomas of the esophagogastric junction.

1 reference

12 December 2020

Clinical utility of 18F-FDG PET for patients with salivary gland malignancies.

1 reference

12 December 2020

The prognostic value of FDG PET in head and neck cancer. Correlation with histopathology

1 reference

12 December 2020

Uptake of (18)F-FLT and (18)F-FDG in primary head and neck cancer correlates with survival.

1 reference

12 December 2020

Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma?

1 reference

12 December 2020

10.1007/S00432-010-0972-Y

Identifiers

DOI

1 reference

24 December 2017

release_3q7ace5abbabjajq5yaeobie7a

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3q7ace5abbabjajq5yaeobie7a

24 November 2022

mapped directly with Wikidata item

PubMed ID

21229262

1 reference

24 December 2017